Contents

Current Pharmaceutical Design, Volume 16 - Number 17

Editorial [Hot topic: Adipocytokines in Nonalcoholic Fatty Liver Disease: Key Players Regulating Steatosis, Inflammation and Fibrosis (Executive Editor: Herbert Tilg)]

, 16(17): 1893 - 1895

Herbert Tilg


DOI: 10.2174/138161210791208929




Adiponectin: A Key Player in Obesity Related Disorders

, 16(17): 1896 - 1901

Yuji Matsuzawa


DOI: 10.2174/138161210791208893




Leptin: The Prototypic Adipocytokine and its Role in NAFLD

, 16(17): 1902 - 1912

Claudio Procaccini, Mario Galgani, Veronica De Rosa, Fortunata Carbone, Claudia La Rocca, Giusy Ranucci, Raffaele Iorio and Giuseppe Matarese


DOI: 10.2174/138161210791208884




Pre-B Cell Colony Enhancing Factor/NAMPT/Visfatin in Inflammation and Obesity- Related Disorders

, 16(17): 1913 - 1920

Alexander R. Moschen, Romana R. Gerner and Herbert Tilg


DOI: 10.2174/138161210791208947




Retinol-Binding Protein 4 and New Adipocytokines in Nonalcoholic Fatty Liver Disease

, 16(17): 1921 - 1928

Anke Tonjes, Matthias Bluher and Michael Stumvoll


DOI: 10.2174/138161210791208938




Role of Adipocytokines in Hepatic Fibrosis

, 16(17): 1929 - 1940

C. Bertolani and F. Marra


DOI: 10.2174/138161210791208857




Insulin Resistance in Nonalcoholic Fatty Liver Disease

, 16(17): 1941 - 1951

E. Bugianesi, S. Moscatiello, M.F. Ciaravella and G. Marchesini


DOI: 10.2174/138161210791208875




Role of microRNAs in Non-Alcoholic Steatohepatitis

, 16(17): 1952 - 1957

Onpan Cheung and Arun J. Sanyal


DOI: 10.2174/138161210791208866




Current and Future Therapeutic Strategies in NAFLD

, 16(17): 1958 - 1962

Nimantha Mark Wilfred de Alwis and Christopher Paul Day


DOI: 10.2174/138161210791208901




In Vitro Evaluation of Potential Hepatotoxicity Induced by Drugs

, 16(17): 1963 - 1977

M.J. Gomez-Lechon, A. Lahoz, L. Gombau, J.V. Castell and M.T. Donato


DOI: 10.2174/138161210791208910




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science